NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-264-2015-0-US-05 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) AND METHODS OF THEIR USE US National Stage 15/761,398 11078286 Issued PDF
NCI E-153-2009-0-US-17 AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE US CON 15/925,148 10421945 Issued PDF
NIBIB E-005-2012-3-US-02 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US DIV 15/924,666 10156711 Issued PDF
NCI E-183-2009-0-EP-07 Schweinfurthins And Uses Thereof EP DIV 18162475.0 Abandoned
NIDA E-017-2018-0-US-01 Novel Biased Potent Opioid-like Agonists As Improved Medications To Treat Chronic And Acute Pain US 62/644,791 Abandoned
NIAID E-080-2013-0-US-07 ATTENUATION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS BY GENOME SCALE CODON-PAIR DEOPTIMIZATION US DIV 15/924,012 1137-10-24 Issued PDF
NEI E-058-2018-0-US-01 USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY AND DIAGNOSTICS US 62/644,175 Abandoned
NCI E-267-2015-1-PCT-02 INHIBITORS OF PROKARYOTIC GENE TRANSCRIPTION AND USES THEREOF PCT PCT PCT/US2018/022703 Expired
NCI E-048-2016-1-US-01 Irreversible Allosteric Inhibitors Of Ubiquitin-conjugating Enzyme Ube2g2 Useful As Anti-metastatic Agents US 62/643,198 Abandoned
NHLBI E-287-2015-2-JP-03 Devices And Methods For Effectuating Percutaneous Glenn And Fontan Procedures JP National Stage 2018-514884 Issued
NCI E-247-2015-0-US-06 IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA US National Stage 15/760,193 10392441 Issued PDF
NHGRI E-177-2015-0-EP-03 CANCER DETECTION METHODS EP National Stage 16774745.0 Abandoned
NCI E-056-2011-0-JP-45 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer JP DIV 2018-046148 Pending
NCI E-097-2018-0-US-01 ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES US 62/643,015 Abandoned
NCI E-265-2015-0-NZ-11 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS NZ National Stage 1974-07-14 Pending
NCI E-265-2015-0-MX-10 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS MX National Stage MX/a/2018/003062 Issued
NHGRI E-177-2015-0-US-04 CANCER DETECTION METHODS US National Stage 15/759,452 10961590 Issued PDF
NCI E-281-2016-0-US-03 Quinolinones As Inhibitors Of Translation Initiation Complex US National Stage 15/554,419 10577349 Issued PDF
NCI E-265-2015-0-US-14 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS US National Stage 15/758,954 10556940 Issued PDF
NCATS E-300-2012-0-US-04 COINCIDENCE REPORTER GENE SYSTEM US DIV 15/916,762 Abandoned
CC E-026-2015-0-CN-03 Repeat Biopsy System And Method CN National Stage 201680052349.7 Pending
NCI E-082-2018-0-US-01 T CELL RECEPTORS WHICH TARGET KK-LC-1 US 62/640,738 Abandoned
NCATS E-253-2017-0-US-01 C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME US 62/641,126 Abandoned
NIAID E-185-2015-0-US-04 EXPRESSION VECTOR DELIVERY SYSTEM AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE US National Stage 15/758,505 10799580 Issued PDF
NIAAA E-007-2003-2-US-06 Synthesis Of The Monoester Of 1,3 Butandiol With A Trimer Of D-Beta-Hydroxybutayrate Using Lipase Catalysis In Nonaqueous Media And Modifications Of This And Other Esters US CON 15/914,676 1123-07-22 Expired PDF
NCI E-028-2015-1-HK-14 Anti-Mutated Kras T Cell Receptors HK EP 18103250.9 Issued
NEI E-212-2015-0-US-07 METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS US National Stage 15/758,314 Abandoned
NEI E-212-2015-0-JP-06 METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS JP National Stage 2018-512373 Pending
CC E-026-2015-0-JP-05 Repeat Biopsy System And Method JP National Stage 2018512368 Pending
NCATS E-095-2017-0-US-03 TREATMENT FOR WOLFRAM SYNDROME AND OTHER ENDOPLASMIC RETICULUM STRESS DISORDERS US National Stage 16/491,826 11426415 Issued PDF
NCI E-243-2015-0-US-04 ANTI-CD276 CHIMERIC ANTIGEN RECEPTORS US National Stage 15/757,728 10562952 Issued PDF
NCATS E-095-2017-0-PCT-02 TREATMENT FOR WOLFRAM SYNDROME AND OTHER ENDOPLASMIC RETICULUM STRESS DISORDERS PCT PCT PCT/US2018/021167 Expired
NHLBI E-157-2019-0-US-03 IMPLANTED MAGNETS RETRIEVAL SYSTEM AND METHOD US DIV 15/912,687 Abandoned
NCI E-081-2018-0-US-01 17-BETA-HYDROXYWITHANOLIDES AND USE THEREOF IN TREATING CANCER US 62/639,337 Abandoned
NCI E-157-2017-0-US-01 METHODS OF PREPARING POPULATIONS OF CELLS AND RETROVIRAL REAGENTS FOR ADOPTIVE CELL IMMUNOTHERAPY US 62/639,272 Abandoned
NINDS E-025-2018-0-US-01 POSITIVE ALLOSTERIC MODULATORS OF DOPAMINE 1 RECEPTOR AND METHOD OF USE THEREOF US 62/639,271 Abandoned
NHLBI E-218-2016-1-US-01 Immunogens, Compositions, And Methods For Treating Dyslipidemia US 62/639,274 Abandoned
CC E-118-2015-0-US-02 Eye Tracking Applications In Computer aided Diagnosis And Image Processing In Radiology US ORD 15/912,126 10839520 Issued PDF
NCI E-090-2018-0-US-01 MEMBRANE-ANCHORED IL-12 US 62/638,498 Abandoned
NCI E-265-2015-0-IL-07 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` IL National Stage 257840 Issued
NCATS E-148-2012-0-AU-10 TOCOPHEROL AND TOCOPHERYL QUINONE DERIVATIVES AS CORRECTORS OF LYSOSOMAL STORAGE DISORDERS AU DIV 2018201544 Issued
NCATS E-117-2018-0-US-01 Discovery Of 2,6-Dimethoxy-4-(5-Phenyl-4-Thiophen-2-yl-1H-Imidazol-2-yl)-Phenol (DPTIP) A Small Molecule Inhibitor Of Neutral Phingomyelinase 2 (nSMase2) For The Treatment Of Neurodegenerative And Oncologic Diseases US 62/636,998 Abandoned
NEI E-091-2018-0-US-01 USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION US 62/637,592 Abandoned
NCI E-057-2017-0-PCT-02 METHOD OF TREATING OBESITY, INSULIN RESISTANCE, NON-ALCOHOLIC
FATTY LIVER DISEASE INCLUDING NON-ALCOHOLIC STEATOHEPATITIS 		PCT PCT PCT/US2018/020333 Expired
NHGRI E-161-2015-0-US-04 A METHOD OF DETECTING MOLECULES IN PROXIMITY TO A TARGET MOLECULE IN A SAMPLE US National Stage 15/756,236 Abandoned
NCI E-244-2015-0-KR-09 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use KR National Stage 2018-7005987 Pending
NIDCR E-190-2015-0-US-04 METHOD AND DEVICE FOR DETECTING ANTIGEN-SPECIFIC ANTIBODIES IN A BIOLOGICAL FLUID SAMPLE BY USING NEODYMIUM MAGNETS US National Stage 15/756,012 10564152 Issued PDF
NHLBI E-284-2015-0-US-04 SEGMENTED MRI CATHETERS AND OTHER INTERVENTIONAL DEVICES US National Stage 15/755,186 10835710 Issued PDF
NIAID E-256-2015-2-US-09 MODIFIED ANTHRAX TOXIN PROTECTIVE ANTIGEN US National Stage 15/755,341 10835593 Issued PDF
NIAID E-294-2016-0-PCT-02 COMPOSITIONS AND METHODS FOR BLOCKING TRANSMISSION OF PLASMODIUM PCT PCT PCT/US2018/019770 Expired